Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Clin Psychopharmacol. 2017 Aug;37(4):394–400. doi: 10.1097/JCP.0000000000000720

Table 5. Participants with New Onset or Worsening Compared to Baseline of Signs or Symptoms on Side Effect Checklist (SEC), by Treatment Group.

Galantamine Oxytocin Placebo P-value*
SEC Item N n % N n % N n %
Abdominal Pain 20 1 5.0 16 2 12.5 20 2 10.0 0.85
Anorexia 20 2 10.0 16 3 18.8 20 3 15.0 0.89
Bruising Easily 20 2 10.0 16 0 0.0 20 0 0.0 0.32
Constipation 20 0 0.0 16 0 0.0 20 0 0.0 1.00
Diarrhea 20 6 30.0 16 3 18.8 20 1 5.0 0.13
Dizziness 20 6 30.0 16 3 18.8 20 1 5.0 0.13
Dry Eye 18 0 0.0 15 1 6.7 17 1 5.9 0.53
Dry Mouth 20 1 5.0 16 3 18.8 20 2 10.0 0.48
Enuresis 20 1 5.0 16 4 25.0 20 0 0.0 0.03
Excessive Tearing 18 1 5.6 15 1 6.7 17 1 5.9 1.00
Fever 20 1 5.0 16 0 0.0 20 0 0.0 1.00
Headache 20 5 25.0 16 2 12.5 20 3 15.0 0.68
Hyperhydrosis 18 0 0.0 15 0 0.0 17 0 0.0 1.00
Hypersalivation 20 3 15.0 16 3 18.8 20 5 25.0 0.78
Insomnia 20 2 10.0 16 3 18.8 20 1 5.0 0.48
Malaise 20 0 0.0 16 3 18.8 20 2 10.0 0.18
Mucosal Ulceration 20 1 5.0 16 1 6.3 20 0 0.0 0.74
Nasal Irritation 18 3 16.7 15 5 33.3 17 4 23.5 0.60
Nausea 20 3 15.0 16 3 18.8 20 1 5.0 0.47
Rash 20 2 10.0 16 2 12.5 20 2 10.0 1.00
Restlessness 20 2 10.0 16 3 18.8 20 3 15.0 0.89
Sedation 20 3 15.0 16 2 12.5 20 2 10.0 1.00
Sore Throat 20 2 10.0 16 1 6.3 20 1 5.0 1.00
Stiffness 20 2 10.0 16 1 6.3 20 2 10.0 1.00
Tinnitus 20 0 0.0 16 0 0.0 19 2 10.5 0.20
Tremor 20 3 15.0 16 1 6.3 20 2 10.0 0.87
Urticaria 20 3 15.0 16 3 18.8 20 3 15.0 1.00
Uterine Contractions 6 0 0.0 2 0 0.0 3 0 0.0 1.00
Vomiting 20 1 5.0 16 2 12.5 20 2 10.0 0.85
Weight Loss 20 1 5.0 16 3 18.8 20 5 25.0 0.22
Wheezing 18 1 5.6 15 2 13.3 17 2 11.8 0.72
*

Fisher's exact test p-value for any difference among treatments